Human hydroxytyrosol's absorption and excretion from a nutraceutical

Journal of Functional Foods

Volumn 23, Issue , 2016, Pages 278-282

  Khymenets, Olha ^a   Crespo, M Carmen ^b   Dangles, Olivier ^c   Rakotomanomana, Njara ^c   Andres Lacueva, Cristina ^a   Visioli, Francesco ^b,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b IMDEA FOOD INSTITUTE   (Spain)

^c UNIVERSITY OF AVIGNON   (France)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bioavailability; Hydroxytyrosol; Mass spectrometry; Metabolites; Polyphenols; Supplements

Indexed keywords

EID: 84960104526     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2016.02.046     Document Type: Article

References (17)

1. Caruso D., Visioli F., Patelli R., Galli C., Galli G. Urinary excretion of olive oil phenols and their metabolites in humans. Metabolism: Clinical and Experimental 2001, 50(12):1426-1428. 10.1053/meta.2001.28073.
2. Crespo M.C., Tome-Carneiro J., Burgos-Ramos E., Loria Kohen V., Espinosa M.I., Herranz J., Visioli F. One-week administration of hydroxytyrosol to humans does not activate Phase II enzymes. Pharmacological Research 2015, 95-96:132-137. 10.1016/j.phrs.2015.03.018.
3. EFSA Panel on Dietetic Products Scientific Opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage (ID 1333, 1638, 1639, 1696, 2865), maintenance of normal blood HDL cholesterol concentrations (ID 1639), maintenance of normal blood pressure (ID 3781), "anti-inflammatory properties" (ID 1882), "contributes to the upper respiratory tract health" (ID 3468), "can help to maintain a normal function of gastrointestinal tract" (3779), and "contributes to body defences against external agents" (ID 3467) pursuant to Article 13 (1) of Regulation (EC) No 1924/2006. EFSA Journal 2011, 9:2033-2058.
4. Giordano E., Dangles O., Rakotomanomana N., Baracchini S., Visioli F. 3-O-hydroxytyrosol glucuronide and 4-O- hydroxytyrosol glucuronide reduce endoplasmic reticulum stress in vitro. Food & Function 2015, 6:3275-3281.
5. Gonzalez-Santiago M., Fonolla J., Lopez-Huertas E. Human absorption of a supplement containing purified hydroxytyrosol, a natural antioxidant from olive oil, and evidence for its transient association with low-density lipoproteins. Pharmacological Research 2010, 61(4):364-370. 10.1016/j.phrs.2009.12.016.
6. Khymenets O., Farré M., Pujadas M., Ortiz E., Joglar J., Covas M.I., Solà R., Farré M., Saez G., de la Torre R. Direct analysis of glucoronidated metabolites of main olive phenols in human urine after dietary consumption of virgin olive oil. Food Chemistry 2011, 126:306-314.
7. Kotronoulas A., Pizarro N., Serra A., Robledo P., Joglar J., Rubio L., de la Torre R. Dose-dependent metabolic disposition of hydroxytyrosol and formation of mercapturates in rats. Pharmacological Research 2013, 77:47-56. 10.1016/j.phrs.2013.09.001.
8. Mahabir S. Methodological challenges conducting epidemiological research on nutraceuticals in health and disease. PharmaNutrition 2014, 2:120-125.
9. Miro-Casas E., Covas M.I., Farre M., Fito M., Ortuño J., Weinbrenner T., Roset P., de la Torre R. Hydroxytyrosol disposition in humans. Clinical Chemistry 2003, 49(6):945-952.
10. Perez-Mana C., Farre M., Pujadas M., Mustata C., Menoyo E., Pastor A., Langohr K., de la Torre R. Ethanol induces hydroxytyrosol formation in humans. Pharmacological Research 2015, 95-96:27-33. 10.1016/j.phrs.2015.02.008.
11. Perez-Mana C., Farre M., Rodriguez-Morato J., Papaseit E., Pujadas M., Fito M., de la Torre R. Moderate consumption of wine, through both its phenolic compounds and alcohol content, promotes hydroxytyrosol endogenous generation in humans. A randomized controlled trial. Molecular Nutrition & Food Research 2015, 59(6):1213-1216. 10.1002/mnfr.201400842.
12. Rubió L., Farras M., de la Torre R., Macià A., Romero M.P., Valls R.M., Sola R., Farre M., Fito M., Motilva M.J. Metabolite profiling of olive oil and thyme phenols after a sustained intake of two phenol-enriched olive oils by humans: Identification of compliance markers. Food Research International 2014, 65:59-68.
13. Tome-Carneiro J., Visioli F. Polyphenol-based nutraceuticals for the prevention and treatment of cardiovascular disease: Review of human evidence. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 2015, 10.1016/j.phymed.2015.10.018.
14. U.S.Department of Health and Human Services Guidance for Industry 2001, Bioanalytical Method Validation.
15. Visioli F., Bernardini E. Extra virgin olive oil's polyphenols: Biological activities. Current Pharmaceutical Design 2011, 17(8):786-804.
16. Visioli F., Galli C., Bornet F., Mattei A., Patelli R., Galli G., Caruso D. Olive oil phenolics are dose-dependently absorbed in humans. FEBS Letters 2000, 468(2-3):159-160.
17. Vissers M.N., Zock P.L., Roodenburg A.J., Leenen R., Katan M.B. Olive oil phenols are absorbed in humans. The Journal of Nutrition 2002, 132(3):409-417.